• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ADVANTIO; IMPLANTABLE PACEMAKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ADVANTIO; IMPLANTABLE PACEMAKER Back to Search Results
Model Number K062
Medical Device Problem Code Under-Sensing (1661)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/27/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that this implantable pacemaker device exhibited undersensing.Sensing fixed was 2.5 milli volts output.As of this time, this device remains in service.No adverse patient effects were reported.
 
Event or Problem Description
It was reported that this implantable pacemaker device exhibited undersensing.Sensing fixed was 2.5 milli volts output.As of this time, this device remains in service.No adverse patient effects were reported.Additional information was received which indicated that this pacemaker was explanted, replaced and was returned for analysis.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.The device was then exposed to simulated heart load conditions, and the pacing and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.
 
Event or Problem Description
It was reported that this implantable pacemaker device exhibited undersensing.Sensing fixed was 2.5 milli volts output.As of this time, this device remains in service.No adverse patient effects were reported.Additional information was received which indicated that this pacemaker was explanted, replaced and was returned for analysis.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTIO
Common Device Name
IMPLANTABLE PACEMAKER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key21618085
Report Number2124215-2025-16258
Device Sequence Number8515657
Product Code LWP
UDI-Device Identifier00802526516658
UDI-Public00802526516658
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
N970003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/09/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date04/11/2016
Device Model NumberK062
Device Catalogue NumberK062
Device Lot Number120919
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/18/2025
Supplement Date Received by Manufacturer07/24/2025
12/15/2025
Initial Report FDA Received Date03/17/2025
Supplement Report FDA Received Date08/19/2025
01/09/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/16/2014
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age81 YR
Patient SexMale
-
-